1/9 Has #Gardasil approval ushered in an era of #overprevention? @RecheckHealth’s @CatherineRiva published on @thejospi an intriguing, original research piece co-signed by MD Jean-Pierre Spinosa: jospi.org/article/18180-… #HPV
2/9 The article tracks back the approval history of the first vaccine to have been granted the FDA’s accelerated approval and fast track. @CatherineRiva and MD @gipispinosa combined published documents with DAPs and correspondence obtained with a #FOIA #Gardasil #HPV
3/9 The authors of @thejospi piece sought to understand how the evaluation criteria were selected during #Gardasil approval and the impact of the FDA experts’ choices on the quality of the available evidence about the vaccine’s efficacy. #Gardasil #HPV
4/9 The article shows that, under the pressure of the fast-track procedure, U.S. regulatory authorities failed to comply with the methodological guidelines supposed to be applied during drugs and vaccines approval (ICH guidelines ich.org). #HPV #Gardasil
5/9 @thejospi published analysis shows that in the approval process of #Gardasil the FDA experts made problematic methodological choices (endpoints, primary and exploratory analysis criteria, etc.) that could only lead to inconclusive results on its efficacy and safety. #EBM
6/9 Gardasil accelerated approval created a new situation in countries where, prior to the introduction of this vaccination, cervical cancer was already prevented by screening with Pap smear. Screening must be maintained because vaccines do not target all high-risk HPV strains.
7/9 Gardasil’s approval has thus inaugurated a new form of medical overuse #overmedicalisation: introduction of a low-value primary prevention measure (vaccination) whose effectiveness can’t be fully assessed, since the secondary prevention measure (screening) cannot be removed.
8/9 This inextricable #overprevention situation allowed Merck to escape the burden of proof while generating huge profits. Health authorities promote the product and the society bears the costs of both vaccination campaigns and potential health risks. #HPV
9/9 Lay person’s summary of findings: re-check.ch/wordpress/en/g…
PDF in open access: jospi.org/article/18180-…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Re-Check

Re-Check Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @RecheckHealth

19 Feb 20
1/
.@Doctors4Assange published in @TheLancet on behalf of 117 signatories hbs.ly/H02z580 “We are calling upon governments to end the torture of #Assange and ensure his access to the best available health care before it’s too late”
2/
.@RecheckHealth co-founders @serenatinari and @CatherineRiva who co-launched #JournalistSpeakUpForAssange fully endorse this appeal
3/
#SRFrundschau will interview tonight @NilsMelzer on #Assange case and the issue of a #humanitarian #visa for him in Canton of #Geneva srf.ch/news/internati…
Read 4 tweets
19 Jan 19
Care to kick off the New Year with a TWEETORIAL? Our humble homage to @VPrasadMDMPH will walk you through the evidence on #HPV vaccines and what @Cochranecollab made of it. Let’s first agree on one thing: RCTs are superior to observational studies
On HPV vaccines many observational studies published and hyped Randomized Controlled Trials on #Gardasil #Cervarix failed to demonstrate the expected efficacy though. It is sad, true and rarely discussed. Let’s have a closer look. @garyschwitzer @HealthNewsRevu @senseaboutsci
In 2006 @US_FDA VRBPAC Committee required @Merck to provide data and analyses on Gardasil RCTs FUTURE I and II.
Which outcome would you consider as the most relevant to assess Gardasil efficacy?
Read 22 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!